Text size
These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material is from Nov. 11 through Nov. 17, 2021. Source: InsiderScore.com
Original Filings
Bird Global (BRDS)
Sequoia Capital revealed a position of 12,304,430 shares in Bird Global, an e-scooter and e-bike manufacturer. The stake resulted from the automatic conversion of convertible preferred securities into common stock on Nov. 4.
On Nov. 5, Bird Rides closed its merger with Switchback II, a special-purpose acquisition firm, or SPAC, to create Bird Global. Sequoia Capital is represented on Bird Global’s board by managing partner Roelof Botha.
Increases In Holdings
Janus Henderson Group (JHG)
Trian Fund Management increased its stake in the asset manager to 26,321,193 shares. Trian purchased 1,714,291 Janus Henderson shares from Oct. 5 to Nov. 15 at prices ranging from $41.63 to $47.54. Trian disclosed that it “continues to engage in discussions with the board and/or management of [Janus Henderson] regarding various strategic and operational initiatives.” Trian also revealed that it is seeking the addition of independent directors, unaffiliated with Trian, to Janus Henderson’s board.
Trian Fund Management now owns a 15.4% interest in Janus Henderson.
Alpine Immune Sciences(ALPN)
OrbiMed Advisors revealed on Nov. 12 that it had raised its position in the biopharmaceutical firm by nearly a third, to 4,226,843 shares, including 145,251 shares that underlie warrants.
On Sept. 17, OrbiMed bought 1,010,637 Alpine Immune shares through a block trade at $9.40 apiece. The purchase marked a reversal in direction for OrbiMed, which had sold 600,000 Alpine Immune shares last December through a block trade at $14.25 per share. OrbiMed now holds a 14.4% interest in Alpine Immune’s outstanding stock.
Decreases In Holdings
Hain Celestial Group (HAIN)
Engaged Capital slashed its stake in the organic food and beverage company to 1,900,792 shares.
Engaged Capital sold 12,379,504 shares through an underwritten offering that priced them at $45.50 a share on Nov. 15. Concurrently, Hain Celestial repurchased 1.7 million shares from Engaged Capital, also at the noted offering price. Additionally, Engaged Capital distributed 50,000 Hain Celestial shares to investors for no consideration.
All told, Engaged Capital dropped its interest in Hain to 2%, which accounts for 33,698 shares held by Engaged founder Glenn Welling, who also serves on Hain’s board of directors.
Engaged said that its large Hain divestment was related to the “required wind-down” of five feeder funds, and “not an indication of [Engaged Capital’s] view on the future prospects” of Hain Celestial Group.
Email: [email protected]
